![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.biospectrumasia.com/news/25/23547/specialised-therapeutics-ascendis-pharma-to-commercialise-endocrinology-therapies-in-australia-and-se-asia.html
https://www.prnewswire.com/news-releases/specialised-therapeutics-signs-exclusive-agreement-with-ascendis-pharma-as-for-distribution-and-commercialisation-of-three-endocrinology-therapies-in-australia-and-select-south-east-asia-countries-302027751.html
https://www.prnewswire.com/news-releases/specialised-therapeutics-signs-exclusive-license-agreement-with-canariabio-for-new-ovarian-cancer-therapy-301954406.html
https://www.pharmaceutical-technology.com/news/specialised-therapeutics-treeway-als/
https://www.prnewswire.com/news-releases/specialised-therapeutics-acquires-commercialisation-rights-to-new-oral-mnd-therapy-301909816.html
https://www.prnewswire.com/news-releases/specialised-therapeutics-signs-partnership-agreement-with-akeso-inc-and-cttq-akeso-to-commercialise-new-anti-pd1-antibody-in-australia-and-southeast-asia-301793985.html